GSK has enlisted the aid of basketball legend Magic Johnson to front an awareness campaign on the dangers of respiratory syncytial virus (RSV) as it prepares for an FDA de
The race to market for a next-generation meningococcal vaccine has gone up a gear once again, with GSK reporting phase 3 results in support of its five-in-one candidate, a
Pfizer UK president Susan Rienow will take the role of president of the Association of the British Pharmaceutical Industry (ABPI) on a full-time basis in May, following th
Eli Lilly’s Verzenio is already one of its fastest-growing products, but could go up another gear following a pair of FDA approvals that expand its eligible patient popula